Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Genzyme responds to Sanofi-Aventis' unsolicited acquisition proposal

Genzyme Corp. today confirmed that it has received an unsolicited, non-binding proposal from Sanofi-Aventis to acquire all the outstanding shares of Genzyme for $69 per share in cash. The Genzyme board of directors met last night, unanimously affirmed its previous rejection of Sanofi's proposal, and instructed the company to send Sanofi the following response letter:

30 Aug 2010

Covidien completes sale of Sleep Therapy CPAP, Bi-level products to PH Invest

Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure and Bi-level products to PH Invest, a privately held company located in Luxembourg. Financial terms of the transaction were not disclosed.

30 Aug 2010

Fosun Pharma increases investment in Chindex

Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, and Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a leading manufacturer and distributor of western and Chinese medicine and devices in China, today announced that they have consummated a previously-announced stock sale.

27 Aug 2010

Medical Action Industries acquires AVID Medical

Medical Action Industries Inc. announced the acquisition of AVID Medical, Inc., a leading provider of custom procedure trays serving the healthcare industry. AVID's product line of custom procedure trays is complementary to Medical Action's leading position in single use medical products. Medical Action expects that the acquisition will increase its ability to serve healthcare providers in acute care facilities and surgery centers.

27 Aug 2010

Smoking among youth declines, but much more needs to be done

The 2009 National Youth Tobacco Survey released today by the Centers for Disease Control and Prevention provides further evidence that the United States has made dramatic progress in reducing youth smoking, but the rate of decline has slowed significantly in recent years.

27 Aug 2010

Shire receives European marketing approval for VPRIV therapy to treat type 1 Gaucher disease

Shire, the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease.

27 Aug 2010

Ricerca Biosciences completes purification of an API under cGMP controls

Ricerca Biosciences, a uniquely integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, is pleased to announce the successful completion of the purification of an active pharmaceutical ingredient (API) under current good manufacturing practices (cGMP) controls.

27 Aug 2010

SYSPRO ERP solution support pharmaceutical manufacturers to new FDA regulation

SYSPRO, the leading provider of visionary, pragmatic ERP software, today announced that the company is highly confident that the SYSPRO ERP solution will enable pharmaceutical manufacturers to meet the new U.S. Food and Drug Administration (FDA) regulations being proposed by Congress.

27 Aug 2010

Xcellerex, SK Chemicals sign memorandum of understanding to expand vaccine business in Korea

Xcellerex, Inc. announced today that it has signed a memorandum of understanding with SK Chemicals, Co., Ltd., one of South Korea's largest industrial groups, for an alliance to develop and commercialize SK-developed vaccines with Xcellerex's FlexFactory biomanufacturing platform. The companies expect to define specific terms of the alliance in the coming months.

26 Aug 2010

Octapharma completes clinical development of Uniplas human pooled plasma

Octapharma AG, one of the largest private manufacturers of plasma products in the world, announced today that the clinical development for Uniplas® has been successfully completed. The product has been filed for registration in Europe and will be submitted later in the USA.

26 Aug 2010

IIC-China to feature live teardown of latest portable blood pressure measurement device

Global Sources announces today that top international and local technology experts are scheduled to speak at the 15th International IC-China Conference & Exhibition Fall Edition. The event, which features mainland China's very first live product teardowns, is set to take place in two major electronics design and manufacturing hubs in Southern and Western China:

26 Aug 2010

AdvanSource receives patent for Antimicrobial Polyurethane Resins to eradicate MRSA

AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.

26 Aug 2010

Phase 1 CRLX101 clinical study paves way for promising innovations in cancer therapy: Cerulean Pharma

Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.

26 Aug 2010

Device firms skid as health IT looks to bright future

As companies look forward to a bright future in some areas of health technology--namely, electronic medical records--other parts of the med-tech industry are watching sales slip.

26 Aug 2010

Cyberonics reports 16% increase in net sales for first quarter 2011

Cyberonics, Inc. today announced results for the quarter ended July 30, 2010.

26 Aug 2010

Angeion Corporation 2010 third quarter revenue increases to $7.1 million

Angeion Corporation today reported results for its fiscal third quarter ended July 31, 2010.

26 Aug 2010

Bohai Pharmaceuticals launches new corporate website

Bohai Pharmaceuticals Group, Inc., a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today announces the launch of a new corporate website for U.S. investors.

25 Aug 2010

NacTel installs and integrates new customer communications system for Drive Medical

NacTel, a leading provider of enterprise telecommunications and data systems has successfully installed and integrated a new state-of-the-art customer communications system for Drive Medical Design & Manufacturing, one of the fastest growing durable medical equipment companies in the world. Drive Medical needed a sophisticated feature set to serve its customers, and chose the ShoreTel UC system, a brilliantly simple unified communication (UC) solution based on its award-winning IP business phone system, installed by NacTel.

25 Aug 2010

Guided Therapeutics receives fund to commercialize LightTouch for cervical cancer detection

Guided Therapeutics, Inc. today announced that it was awarded $1.0 million to fund the second year of a $2.5 million grant from the National Cancer Institute (NCI) announced in 2009.

25 Aug 2010

WHO grants prequalification status to pneumococcal vaccine, paving way for U.N. procurement

The WHO "has granted prequalification status to Pfizer Inc.'s children's pneumococcal vaccine, Prevenar 13, paving the way for United Nations agencies and governments to start ordering the product," the Associated Press reports (8/23).

25 Aug 2010

Manufacturing News and Research

Further Reading

Genzyme responds to Sanofi-Aventis' unsolicited acquisition proposal

Covidien completes sale of Sleep Therapy CPAP, Bi-level products to PH Invest

Fosun Pharma increases investment in Chindex

Medical Action Industries acquires AVID Medical

Smoking among youth declines, but much more needs to be done

Shire receives European marketing approval for VPRIV therapy to treat type 1 Gaucher disease

Ricerca Biosciences completes purification of an API under cGMP controls

SYSPRO ERP solution support pharmaceutical manufacturers to new FDA regulation

Xcellerex, SK Chemicals sign memorandum of understanding to expand vaccine business in Korea

Octapharma completes clinical development of Uniplas human pooled plasma

IIC-China to feature live teardown of latest portable blood pressure measurement device

AdvanSource receives patent for Antimicrobial Polyurethane Resins to eradicate MRSA

Phase 1 CRLX101 clinical study paves way for promising innovations in cancer therapy: Cerulean Pharma

Device firms skid as health IT looks to bright future

Cyberonics reports 16% increase in net sales for first quarter 2011

Angeion Corporation 2010 third quarter revenue increases to $7.1 million

Bohai Pharmaceuticals launches new corporate website

NacTel installs and integrates new customer communications system for Drive Medical

Guided Therapeutics receives fund to commercialize LightTouch for cervical cancer detection

WHO grants prequalification status to pneumococcal vaccine, paving way for U.N. procurement

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News